# Enable EMA Clinical Trial Submissions: Non-Study Suspect Products

Learn how to configure your Vault to support submitting Clinical Trial Cases to the EMA with the Spontaneous Report Type.

## About the Feature

With the 23R3 release, Vault Safety supports submitting Clinical Trial Cases with the Spontaneous Report Type. This feature aligns with the European Union (EU) Good Vigilance Practice (GVP) Module VI guidelines, particularly for Clinical Trial Cases involving adverse events related solely to non-investigational medicinal products available in the EU. To accomplish this, a new **Report Type Override** field on _Transmissions_ enables overriding the Report Type at the _Transmission_ level. This feature enhances compliance with regulatory requirements.

Once you have configured the feature, see <a href="/en/lr/1022564/#report-type-override">Create an ICSR _Transmission_</a> and <a href="/en/lr/700007/">E2B Generation: EMA E2B(R3) Mapping</a> for more details.

## Add Report Type Override to Transmission Layouts

Complete the following steps to add the **Report Type Override** field to the **Transmission** object:

1. Go to **Admin > Configuration > Objects > Transmission > Layouts > Submission Detail Page Layout**.
2. In the **Details** section, add the **Report Type Override** field.
3. Select **Save**.